High-Load, Low-Load, and Passive Blood Flow Restriction in Competitive Sprinters

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-30
SponsorRiphah International University

About this trial

This randomized clinical trial will include competitive male and female sprinters aged 16-30 years, recruited through purposive sampling. Participants will be randomly assigned to one of three groups: (A) HL-BFR (70-85% 1RM with BFR during sets), (B) LL-BFR (20-30% 1RM with BFR), or (C) Passive BFR (BFR applied between sets). The intervention will consist of a 6-week sprint-specific resistance training program performed thrice weekly, incorporating resisted sprints, barbell step-ups, hip thrusts, Nordic curls, and bounding exercises. Strength will be measured using 1RM testing, explosive power through countermovement and standing broad jumps, and sprint performance via 10m, 30m, and 100m timed sprints. Subjective exertion will be tracked using the sRPE scale.

The study aims to determine whether HL-BFR, LL-BFR, or passive BFR produces superior improvements in sprint performance and neuromuscular strength. It is hypothesized that HL-BFR may yield greater adaptations due to combined mechanical and metabolic stress, though LL-BFR and passive BFR may offer practical, low-impact alternatives.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age between 16-30 years

Competitive sprinters with at least 2 years of sprint-specific training

Healthy individuals without cardiovascular, metabolic, musculoskeletal, or neurological disorders

Willingness to participate in a 6-week training program

Disqualifiers

Pregnancy or lactation

Cardiovascular, vascular, pulmonary, renal or metabolic disorders

Uncontrolled hypertension

Recent significant weight loss

Trial design

Design model

Parallel

Treatments tested in this trial

  • High-Load Blood Flow Restriction Training (HL-BFR)

    Other intervention

    In the High-Load BFR group, participants will perform resistance exercises at 70-85% of one-repetition maximum (1RM) with BFR applied during exercise sets.

  • Low-Load Blood Flow Restriction Training (LL-BFR)

    Other intervention

    In the Low-Load BFR group, participants will perform resistance exercises at 20-30% of one-repetition maximum (1RM) with BFR applied during exercise sets.

  • Passive Blood Flow Restriction Training (PBFR)

    Other intervention

    In the Passive BFR group, participants will perform resistance exercises at 70-85% of one-repetition maximum (1RM) with BFR applied only during rest intervals between sets.

Treatment groups

18 Participants
are divided into 3 treatment groups
Group A: High-Load Blood Flow Restriction Training (HL-BFR)Experimental treatment 1 intervention
Group B: Low-Load Blood Flow Restriction Training (LL-BFR)Experimental treatment 1 intervention
Group C: Passive Blood Flow Restriction Training (PBFR)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Lower Limb Muscle Strength (1RM Test)

Maximum voluntary strength of lower limb muscles will be assessed using one repetition maximum (1RM) testing protocol for resistance training exercises.

Time frame
Baseline (Week 0) and Post-Intervention (Week 6)

Secondary outcomes

1

Vertical Jump Height

Explosive lower limb power will be assessed using vertical jump performance test measured in centimeters.

Time frame
Baseline (Week 0) and Post-Intervention (Week 6)
2

10-Meter Sprint Time

Sprint performance over short distance will be measured using timing gates in seconds.

Time frame
Baseline (Week 0) and Post-Intervention (Week 6)
3

30-Meter Sprint Time

Sprint acceleration and performance will be measured using electronic timing system in seconds.

Time frame
Baseline (Week 0) and Post-Intervention (Week 6)
4

100-Meter Sprint Time

Overall sprint performance will be assessed using timing system in seconds.

Time frame
Baseline (Week 0) and Post-Intervention (Week 6)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.